PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

A Phase 1 Study of LY2835219 In Participants With Advanced Cancer

A Phase 1 Study of LY2835219 In Participants With Advanced Cancer


Basic Trial Information

Protocol Phase:Phase I
Study Category:Treatment
Current Protocol StatusActive
Age18 and over
Protocol SponsorPharmaceutical/Industry
Primary ID13199
Other IDNCT01394016
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: